Profit by knowlytics
A flare-up of war in West Asia has shaken oil, bond and other markets again, but, curiously, gold prices have slid amid rising uncertainty. Are the dynamics that gave gold its spectacular global bull run shifting?
Be it Amartya Sen’s tackle of Arrow’s impossibility theorem on social choice or India’s fuzzy-logic position on a macro trilemma in the face of a dollar in-surge, what cannot be done can also get minds whirring. It’s why all eyes are on RBI.
A Mumbai taxpayer’s ₹12.62 lakh LTCG exemption claim was denied due to suspected price manipulation. However, the ITAT ruled in the taxpayer’s favour. Here’s why.
ISRO on Friday made its way into history books yet again with the successful launch of the country’s first ever imaging satellite in geo-orbit, placing the over 2,300 kg payload into a precise orbit using a GSLV rocket. Friday’s launch marked the space agency’s maiden success for the year 2026. The EOS-05 satellite was successfully…
ISRO chief V Narayanan on Friday said that “vigorous, systematic work,” is on for the launch of the first uncrewed Gaganyaan mission during this calendar year. The launch of the earth observation satellite (GSLV-F17/EOS-05) is the first success for ISRO during this financial year, Narayanan said adding, “reward for hard work is more work.” Accordingly,…
To facilitate the identification of mortal remains of Nepal flood victims, the Centre will make available the services of central and state-level forensic labs for DNA profiling of their first-degree biological relatives in India, the MEA said on Thursday. First-degree biological relatives residing in India, i.e. father, mother, son, daughter or sibling, may have their…
Drug major Cipla Ltd on Thursday said its wholly owned subsidiary, Invagen Pharmaceuticals Inc, has entered into a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to the cancer drug Keytruda in the United States. The product, QL2107, is a biosimilar to pembrolizumab (Keytruda) and aims to improve access to…
Volkswagen’s board of directors on Thursday approved a sweeping cost-cutting plan that would see 50,000 jobs cuts, slim its model line by half and end auto production at four German plants. On top of 50,000 job losses already previously agreed, the company would lose 100,000 positions. The plan put forward by CEO Oliver Blume to…
Today’s opinions examine rising global borrowing costs, Lionel Messi’s longevity, governance in financial institutions, foreign investment risks in strategic startups and a new book of essays
Carrefour has re-entered the Indian market after a decade, adopting a new strategy focused on physical stores despite the rise of quick commerce.